| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Aneesh K Tosh | |
| Anthony M Belenchia | |||
| Catherine A Peterson | |||
| P2860 | cites work | Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP | Q22251081 |
| Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation | Q22306203 | ||
| Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline | Q22306207 | ||
| Establishing a standard definition for child overweight and obesity worldwide: international survey | Q24643889 | ||
| Natural vitamin D content in animal products | Q26823585 | ||
| Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis | Q26862535 | ||
| Vitamin D deficiency | Q27860616 | ||
| Risk assessment for vitamin D | Q28282327 | ||
| Pharmacokinetics of vitamin D toxicity | Q28290163 | ||
| Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger | Q28304126 | ||
| The adipocyte-secreted protein Acrp30 enhances hepatic insulin action | Q28505765 | ||
| Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats | Q28573152 | ||
| Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts | Q28709200 | ||
| Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010 | Q29614504 | ||
| Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q29616834 | ||
| Vitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trial | Q30796481 | ||
| Vitamin D fortification in the United States and Canada: current status and data needs | Q30977960 | ||
| Sources, factors, mechanisms and possible solutions to pollutants in marine ecosystems | Q31134652 | ||
| Prevalence and trends in obesity and severe obesity among children in the United States, 1999-2012. | Q39214060 | ||
| Vitamin D status and glucose homeostasis in obese children and adolescents living in the tropics | Q39363690 | ||
| High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors | Q39756202 | ||
| Identification of a Vitamin D response element in the human insulin receptor gene promoter | Q40652874 | ||
| Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). | Q40717321 | ||
| Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children | Q41003960 | ||
| 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion | Q41476591 | ||
| The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer | Q42442425 | ||
| PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein | Q42826174 | ||
| Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children | Q43528826 | ||
| Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates | Q43670535 | ||
| Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents | Q43746741 | ||
| Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease | Q43841173 | ||
| Effect of 1 alpha,25-dihydroxy vitamin D3 and vitamin E on insulin-induced glucose uptake in rat adipocytes | Q43890321 | ||
| Prevalence of impaired glucose tolerance among children and adolescents with marked obesity | Q43917576 | ||
| Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone | Q44238663 | ||
| Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor | Q44292785 | ||
| Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes | Q44312736 | ||
| Overview of the conference "Vitamin D and Health in the 21st Century: an Update". | Q44484803 | ||
| Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. | Q44598687 | ||
| Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial. | Q44806527 | ||
| Prospective association of 25(OH)D with metabolic syndrome | Q44871210 | ||
| Two methods for direct assessment of the Vitamin D synthetic capacity of sunlight and artificial UV sources | Q44958332 | ||
| Leptin, vitamin D, and cardiorespiratory fitness as risk factors for insulin resistance in European adolescents: gender differences in the HELENA Study | Q44984071 | ||
| The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. | Q45929872 | ||
| Prevalence of vitamin D deficiency among overweight and obese US children | Q46217834 | ||
| Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season | Q46282196 | ||
| Betulinic acid and 1,25(OH)₂ vitamin D₃ share intracellular signal transduction in glucose homeostasis in soleus muscle | Q46315533 | ||
| Serum vitamin D increases with weight loss in obese subjects 6 months after Roux-en-Y gastric bypass | Q46410031 | ||
| Lower-body fat mass as an independent marker of insulin sensitivity--the role of adiponectin | Q46433356 | ||
| Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents | Q46527118 | ||
| Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial | Q46777610 | ||
| Scientific Opinion on the Tolerable Upper Intake Level of vitamin D | Q47152099 | ||
| Vitamin D status and parathyroid hormone in obese children before and after weight loss | Q47278399 | ||
| Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth | Q47424075 | ||
| Molecular mechanisms of vitamin D action | Q38025329 | ||
| Contributions of sunlight and diet to vitamin D status | Q38045787 | ||
| Vitamin D signalling in adipose tissue. | Q38050560 | ||
| Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies | Q38056255 | ||
| Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature | Q38059851 | ||
| Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches | Q38107099 | ||
| Vitamin D in the healthy European paediatric population | Q38109505 | ||
| Estimate of a predictive cut-off value for serum 25-hydroxyvitamin D reflecting abdominal obesity in Korean adolescents | Q47431786 | ||
| When should we measure vitamin D concentration in clinical practice? | Q47832017 | ||
| A cross-sectional study of vitamin D and insulin resistance in children | Q48316084 | ||
| Multinutrient-fortified juices improve vitamin D and vitamin E status in children: a randomized controlled trial | Q50762424 | ||
| Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes | Q51038506 | ||
| Prospective associations of vitamin D status with β-cell function, insulin sensitivity, and glycemia: the impact of parathyroid hormone status. | Q51321823 | ||
| Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. | Q51332525 | ||
| Inverse relationship between vitamin D status and insulin resistance and the risk of impaired fasting glucose in Korean children and adolescents: the Korean National Health and Nutrition Examination Survey (KNHANES) 2009-2010. | Q51334009 | ||
| The relation of vitamin D deficiency with puberty and insulin resistance in obese children and adolescents. | Q51357091 | ||
| Adiponectin, adiposity, and insulin resistance in children and adolescents. | Q51501719 | ||
| Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. | Q51826744 | ||
| Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. | Q53104033 | ||
| Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake. | Q53424155 | ||
| Vitamin D status and bone mineral density of veiled and unveiled Turkish women. | Q53463573 | ||
| 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines | Q56089633 | ||
| Teenage girls and elderly women living in northern Europe have low winter vitamin D status | Q56089677 | ||
| Unraveling the effects of 1,25(OH)2D3 on global gene expression in pancreatic islets | Q56110942 | ||
| Vitamin D Status is Linked to Biomarkers of Oxidative Stress, Inflammation, and Endothelial Activation in Obese Children | Q59085865 | ||
| Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity | Q61443770 | ||
| Treatment of hypovitaminosis D with pharmacologic doses of cholecalciferol, oralvsintramuscular; an open labeled RCT | Q63515772 | ||
| The distribution and storage of vitamin D and its metabolites in human tissues | Q68648717 | ||
| Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion | Q70260011 | ||
| Stimulatory effect of 1,25-dihydroxyvitamin D3 on calcium handling and insulin secretion by islets from vitamin D3-deficient rats | Q72537821 | ||
| Longitudinal study of physiologic insulin resistance and metabolic changes of puberty | Q79301827 | ||
| Calculated ultraviolet exposure levels for a healthy vitamin D status | Q80226475 | ||
| Vitamin D insufficiency is associated with diabetes risk in Native American children | Q82150871 | ||
| Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents | Q82819780 | ||
| A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus? | Q82953853 | ||
| Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity | Q83288672 | ||
| The 2011 report on dietary reference intakes for calcium and vitamin D | Q83862294 | ||
| Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents | Q84553584 | ||
| Over-the-counter and compounded vitamin D: is potency what we expect? | Q86096182 | ||
| Recommended vitamin D intake and management of low vitamin D status in adolescents: a position statement of the society for adolescent health and medicine | Q86844952 | ||
| Focus on vitamin D, inflammation and type 2 diabetes | Q35749555 | ||
| The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. | Q35841138 | ||
| 25-hydroxyvitamin D concentrations and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in black and white youth | Q35879062 | ||
| Circulating 25-hydroxyvitamin D concentrations are correlated with cardiometabolic risk among American black and white adolescents living in a year-round sunny climate. | Q35898193 | ||
| Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system | Q35976984 | ||
| Dosing error with over-the-counter vitamin D supplement: a risk for vitamin D toxicity in infants | Q36094951 | ||
| The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis | Q36158245 | ||
| The Effect of Puberty on Interaction between Vitamin D Status and Insulin Resistance in Obese Asian-Indian Children | Q36205624 | ||
| Vitamin D physiology | Q36430932 | ||
| Vitamin D up-regulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-γ-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes | Q36452042 | ||
| Food sources of energy and nutrients among children in the United States: National Health and Nutrition Examination Survey 2003–2006 | Q36607687 | ||
| The ratio of parathyroid hormone to vitamin D is a determinant of cardiovascular risk and insulin sensitivity in adolescent girls | Q36672436 | ||
| Vitamin d deficiency and insufficiency in obese children and adolescents and its relationship with insulin resistance | Q36757888 | ||
| The metabolic syndrome in children and adolescents - an IDF consensus report | Q36938565 | ||
| 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. | Q36942229 | ||
| Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein | Q37000530 | ||
| Development of a WHO growth reference for school-aged children and adolescents | Q37085013 | ||
| Cardiometabolic risk factors related to vitamin d and adiponectin in obese children and adolescents | Q37091052 | ||
| Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults | Q37105776 | ||
| Vitamin D status: measurement, interpretation, and clinical application | Q37105927 | ||
| Association between serum vitamin d and metabolic risk factors in korean schoolgirls | Q37156297 | ||
| Vitamin D deficiency in children and its management: review of current knowledge and recommendations. | Q37234071 | ||
| Vitamin D deficiency: a global perspective | Q37290276 | ||
| Diabetes screening, diagnosis, and therapy in pediatric patients with type 2 diabetes. | Q37299682 | ||
| Vitamin D status and childhood health. | Q37306909 | ||
| Metformin for obesity in children and adolescents: a systematic review | Q37319254 | ||
| Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions | Q37431392 | ||
| Vitamin D and adolescents: what do we know? | Q37510541 | ||
| Vitamin D in health and disease: an insight into traditional functions and new roles for the 'sunshine vitamin'. | Q37629913 | ||
| Vitamin D and DBP: the free hormone hypothesis revisited. | Q37685960 | ||
| Vitamin D3 distribution and status in the body | Q37691143 | ||
| Prevalence of abdominal obesity in adolescents: a systematic review | Q37762844 | ||
| Low vitamin D status among obese adolescents: prevalence and response to treatment | Q37866462 | ||
| Worldwide vitamin D status | Q37923124 | ||
| Where is the vitamin D receptor? | Q38002664 | ||
| What is new in vitamin D: 2006-2007. | Q33286804 | ||
| Relation of body fat indexes to vitamin D status and deficiency among obese adolescents | Q33488449 | ||
| Pediatric non-alcoholic fatty liver disease: New insights and future directions | Q33563887 | ||
| Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents | Q33644445 | ||
| Estimation of total usual calcium and vitamin D intakes in the United States | Q33727956 | ||
| Vitamin D(3) in fat tissue | Q33731843 | ||
| Vitamin D deficiency and insulin resistance in obese African-American adolescents | Q33814185 | ||
| Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. | Q33912394 | ||
| Decreased bioavailability of vitamin D in obesity | Q33916095 | ||
| Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease | Q33983615 | ||
| Vitamin D and its role in skeletal muscle | Q33983914 | ||
| Benefits and requirements of vitamin D for optimal health: a review. | Q33988208 | ||
| Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat | Q34058504 | ||
| Vitamin D and inflammation | Q34149083 | ||
| Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol | Q34166759 | ||
| Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health | Q34203740 | ||
| Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. | Q34225331 | ||
| Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females | Q34230911 | ||
| Expression of adiponectin receptors in pancreatic beta cells | Q34280547 | ||
| Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials | Q34404297 | ||
| The biology of hyperpigmentation syndromes | Q34409196 | ||
| Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density | Q34553230 | ||
| 1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes. | Q34700576 | ||
| Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery | Q34731778 | ||
| Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
| Gene expression profiles in human and mouse primary cells provide new insights into the differential actions of vitamin D3 metabolites | Q35014417 | ||
| Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial | Q35125338 | ||
| Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. | Q35203692 | ||
| Prevalence of the insulin resistance syndrome in obesity | Q35280627 | ||
| Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial | Q35281372 | ||
| No relationship between vitamin D status and insulin resistance in a group of high school students | Q35632301 | ||
| Vitamin D deficiency in obese children and its relationship to glucose homeostasis | Q35654245 | ||
| Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines | Q35664406 | ||
| P433 | issue | 6 | |
| P921 | main subject | obesity | Q12174 |
| vitamin D | Q175621 | ||
| insulin resistance | Q1053470 | ||
| teenager | Q1492760 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 166-189 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Therapeutic advances in endocrinology and metabolism | Q26853790 |
| P1476 | title | Vitamin D insufficiency and insulin resistance in obese adolescents | |
| P478 | volume | 5 |
| Q40828032 | 25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese. |
| Q40475123 | Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density. |
| Q47100808 | Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role? |
| Q48042393 | Current Evidence on Vitamin D Deficiency and Metabolic Syndrome in Obese Children: What Does the Evidence from Saudi Arabia Tell Us? |
| Q63683530 | Differential associations of ferritin and 25‐hydroxyvitamin D with fasting glucose and diabetes risk in community dwelling older men |
| Q45065424 | Higher Dietary Intake of Vitamin D May Influence Total Cholesterol and Carbohydrate Profile Independent of Body Composition in Men with Chronic Spinal Cord Injury. |
| Q92486032 | Obesity and hypovitaminosis D: causality or casualty? |
| Q35672634 | Patients with Active Acromegaly are at High Risk of 25(OH)D Deficiency |
| Q37157167 | The Association of Adiposity Indices and Plasma Vitamin D in Young Females in Saudi Arabia |
| Q54938204 | The association of VDR polymorphisms and type 2 diabetes in older people living in community in Santiago de Chile. |
| Q92713226 | The relationship between cardiometabolic risks and vitamin D levels with the degree of obesity |
| Q41461079 | VDR Gene variation and insulin resistance related diseases |
| Q100385908 | Vitamin D deficiency serves as a precursor to stunted growth and central adiposity in zebrafish |
Search more.